However, the mRNA level of PARP1 in whole blood was somehow decreased in the tumor group and the higher protein level of PARP1 in LUAD was correlated to a better prognosis, meanwhile, its autoantibody was surprisingly decreased in the post-operation group. This evidence concerns the gene PARP1 and neoplasm.